The role of the NIS (SLC5A5) gene in Papillary thyroid cancer : a systematic review

Papillary thyroid cancer (PTC) is the most common thyroid malignancy. Genetic and epigenetic alterations play a decisive role in the onset of several human neoplasms. Mutations and polymorphisms are two frequent genetic alterations. Located on chromosome 19 (19p13.11), the NIS SLC5A5 (solute carrier...

Full description

Main Authors: Morais, Rafael Martins de, Barra Sobrinho, Alaor, Silva, Calliandra Maria de Souza, Oliveira, Jamila Reis de, Silva, Izabel Cristina Rodrigues da, Nóbrega, Otávio de Toledo
Format: Artigo
Language: Inglês
Published: Hindawi 2019
Subjects:
Online Access: http://repositorio.unb.br/handle/10482/34070
https://doi.org/10.1155/2018/9128754
Tags: Add Tag
No Tags, Be the first to tag this record!
Summary: Papillary thyroid cancer (PTC) is the most common thyroid malignancy. Genetic and epigenetic alterations play a decisive role in the onset of several human neoplasms. Mutations and polymorphisms are two frequent genetic alterations. Located on chromosome 19 (19p13.11), the NIS SLC5A5 (solute carrier family 5 member 5) gene encodes a highly specialized and efficient 80–90 kDa transmembrane glycoprotein that mediates active transport of iodide from the bloodstream into the follicular cells. Given the highly significant role of NIS in the physiology and the cancer pathogenesis process, this paper’s objective is to provide a comprehensive assessment of the associations between NIS gene and protein with papillary thyroid cancer.